DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer
- PMID: 24481854
- DOI: 10.1007/s10120-014-0340-8
DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer
Erratum in
-
Correction to: DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer.Gastric Cancer. 2022 Nov;25(6):1136-1138. doi: 10.1007/s10120-022-01341-6. Gastric Cancer. 2022. PMID: 36136226 No abstract available.
Abstract
Background: MicroRNAs act as tumor suppressors or oncogenes. The pathological roles of miRNAs in gastric tumorigenesis are largely unknown. Although miR-10b was identified as an miRNA deregulator expressed in gastric cancer (GC), there also exists some debate on whether miR-10b is acting as tumor suppressor or oncogene in GC.
Methods: Quantitative RT-PCR was employed to investigate the level of miR-10b in GC tissues and matched adjacent normal tissues (n = 100). In vitro cell proliferation, apoptosis assays, cell migration, and invasion assays were performed to elucidate the biological effects of miR-10b. Because silencing of miRNA by promoter CpG island methylation may be an important mechanism in tumorigenesis, GC cells were treated with 5-aza-2'-deoxycytidine and trichostatin A, and expression changes of miR-10b were subsequently examined by quantitative RT-PCR. Furthermore, the methylation status of the CpG island upstream of miR-10b was analyzed by methylation-specific PCR in GC tissues (n = 29).
Results: We showed here that miR-10b was significantly downregulated in GC cell lines and tissues as demonstrated by quantitative real-time PCR. Overexpression of miR-10b in MGC-803 and HGC-27 dramatically suppressed cell proliferation, migration, invasion, and induced apoptosis. Moreover, we demonstrated that T-cell lymphoma invasion and metastasis (Tiam1) was a target of miR-10b. Furthermore, 5-aza-2'-deoxycytidine and trichostain A increased miR-10b expression, and the methylation level was high in the CpG islands upstream of miR-10b gene.
Conclusions: Taken together, these findings suggest that miR-10b may function as a novel tumor suppressor and is partially silenced by DNA hypermethylation in GC.
Similar articles
-
The role and mechanism of action of microRNA-122 in cancer: Focusing on the liver.Int Immunopharmacol. 2023 Oct;123:110713. doi: 10.1016/j.intimp.2023.110713. Epub 2023 Jul 29. Int Immunopharmacol. 2023. PMID: 37523968 Review.
-
Iroquois Family Genes in Gastric Carcinogenesis: A Comprehensive Review.Genes (Basel). 2023 Mar 1;14(3):621. doi: 10.3390/genes14030621. Genes (Basel). 2023. PMID: 36980893 Free PMC article. Review.
-
miR-10b Downregulated by DNA Methylation Acts as a Tumor Suppressor in HPV-Positive Cervical Cancer via Targeting Tiam1.Cell Physiol Biochem. 2018;51(4):1763-1777. doi: 10.1159/000495680. Epub 2018 Nov 30. Cell Physiol Biochem. 2018. PMID: 30504727
-
Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.Int J Oncol. 2014 Dec;45(6):2576-86. doi: 10.3892/ijo.2014.2667. Epub 2014 Sep 23. Int J Oncol. 2014. PMID: 25270964
-
MicroRNA-219-2-3p functions as a tumor suppressor in gastric cancer and is regulated by DNA methylation.PLoS One. 2013 Apr 23;8(4):e60369. doi: 10.1371/journal.pone.0060369. Print 2013. PLoS One. 2013. Retraction in: PLoS One. 2023 Mar 29;18(3):e0282980. doi: 10.1371/journal.pone.0282980. PMID: 23637748 Free PMC article. Retracted.
Cited by
-
"Salivary LINC00657 and miRNA-106a as diagnostic biomarkers for oral squamous cell carcinoma, an observational diagnostic study".BMC Oral Health. 2023 Dec 12;23(1):994. doi: 10.1186/s12903-023-03726-0. BMC Oral Health. 2023. PMID: 38087258 Free PMC article.
-
Retraction: TOX Acts an Oncological Role in Mycosis Fungoides.PLoS One. 2023 May 4;18(5):e0283114. doi: 10.1371/journal.pone.0283114. eCollection 2023. PLoS One. 2023. PMID: 37141222 Free PMC article. No abstract available.
-
Research hotspots and trends of microRNAs in intervertebral disc degeneration: a comprehensive bibliometric analysis.J Orthop Surg Res. 2023 Apr 15;18(1):302. doi: 10.1186/s13018-023-03788-4. J Orthop Surg Res. 2023. PMID: 37061725 Free PMC article.
-
miRNA: A Promising Therapeutic Target in Cancer.Int J Mol Sci. 2022 Sep 29;23(19):11502. doi: 10.3390/ijms231911502. Int J Mol Sci. 2022. PMID: 36232799 Free PMC article. Review.
-
The Advances in Epigenetics for Cancer Radiotherapy.Int J Mol Sci. 2022 May 18;23(10):5654. doi: 10.3390/ijms23105654. Int J Mol Sci. 2022. PMID: 35628460 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous